Format

Send to

Choose Destination
Nephron Clin Pract. 2011;119(2):c89-94; discussion c96. doi: 10.1159/000326682. Epub 2011 Jun 15.

Drug-induced nephrotoxicity in inflammatory bowel disease.

Author information

1
Department of Gastroenterology, University of Thessaly, School of Medicine, Larissa, Greece. acoseko@yahoo.com

Abstract

Conservative management of inflammatory bowel disease (IBD) is based on a combination of drugs, including aminosalicylates (ASAs), steroids, antibiotics, immunosuppressives and biologic agents. Although various side effects have been related to treatment regimens, drug-induced nephrotoxicity is rather uncommon. Furthermore, it is often underestimated since renal function deterioration may be attributed to the underlying disease. The nephrotoxicity of ASAs and cyclosporine A seems well established, but recent data have suggested a possible role of biologic agents such as infliximab and adalimubab in renal impairment. The aim of this review is to summarize the nephrotoxic effects of medical treatment as well as to express possible caveats in the administration of novel agents in IBD.

PMID:
21677443
DOI:
10.1159/000326682
[Indexed for MEDLINE]
Free full text

Supplemental Content

Full text links

Icon for S. Karger AG, Basel, Switzerland
Loading ...
Support Center